ArticleHaematologica2011
Phase I study of sorafenib in patients with refractory or relapsed acute leukemias.
Gautam Borthakur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this paperpooled ittrialcites it